Strategic partnerships Form potential alliances with health tech platforms and AI governance providers to broaden market access, leveraging SimBioSys’s AI-driven tumor modeling and upcoming TumorSight Viz offerings through integration with external model hubs and governance suites.

Clinical validation Leverage recent multi-institutional study data and upcoming MBCC and ASBrS presentations to secure clinician endorsements and demand for AI-powered surgical planning tools, emphasizing improved decision support and personalized care.

Expansion opportunities Target mid-to-large healthcare networks and breast cancer centers seeking precision medicine enhancements; propose deployment of TumorSight Viz and visualization capabilities to support surgical planning and outcome forecasting.

Regulatory readiness Highlight FDA-cleared aspects of TumorSight alongside governance integration to reassure buyers about compliance, risk management, and streamlined adoption within hospital IT and workflow systems.

Technology leverage Promote cloud-based AI and biophysical modeling capabilities to potential customers using modern tech stacks; emphasize interoperability with platforms like Docker, Google Cloud, GitLab, and Jira to ease integration and scaling.